[1]
Mullokulov J.J., Akhmedov Kh.S., “COMPARATIVE EFFICACY AND SAFETY OF BARICITINIB PLUS SULFASALAZINE VERSUS TNF-Α INHIBITORS AND SULFASALAZINE MONOTHERAPY IN REACTIVE ARTHRITIS: A 12-MONTH RANDOMIZED STUDY”, ВАПЦА, vol. 13, no. 8, pp. 21–26, Oct. 2025, Accessed: Nov. 19, 2026. Available: https://journals.tnmu.uz/index.php/bapca/article/view/2469